Metraipolis › archive › dc_fa6a6c7dcd3c

Clinical Validity of NETest2.0® in Surveillance of Neuroendocrine Tumor Patients: Evidence from a NET Registry Study (NCT02270567) — Europe PMC PMID:42122254

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42122254
DOI
10.3390/cancers18091457
License (as archived)
solo-consultazione
Archived
2026-11-02T19:55:19.810Z
SHA-256 of the archived text
5ca4ec5159985e6f4af235be5dd5d9b29e99019d7e3947c74e97920bda09c255
Stable URL of this page
https://metraipolis.com/documento/dc_fa6a6c7dcd3c

How to cite

Clinical Validity of NETest2.0® in Surveillance of Neuroendocrine Tumor Patients: Evidence from a NET Registry Study (NCT02270567) — Europe PMC PMID:42122254 — Europe PMC (en), https://europepmc.org/article/MED/42122254 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fa6a6c7dcd3c (Metraipolis archive dc_fa6a6c7dcd3c, sha256 5ca4ec5159985e6f4af235be5dd5d9b29e99019d7e3947c74e97920bda09c255)
BibTeX
@misc{dcfa6a6c7dcd3c,
  title = {Clinical Validity of NETest2.0® in Surveillance of Neuroendocrine Tumor Patients: Evidence from a NET Registry Study (NCT02270567) — Europe PMC PMID:42122254},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42122254},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fa6a6c7dcd3c; sha256 5ca4ec5159985e6f4af235be5dd5d9b29e99019d7e3947c74e97920bda09c255},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42122254. Agents can read the archived copy with the MCP tool read_document.